History
Creating a bright future through challenges and changes.
Global Expansion ( 2011~ )
- 2019
-
- Merge of ATGen and NKMAX Co., Ltd. / Changed the company name to “NKMAX.”
- Clinical Phase 1 approved for Immunotherapy SuperNK® in the U.S.
- Clinical Phase 1/2a approved for Immunotherapy SuperNK® in Korea.
- Patent registration completed for NK VUE (4 patents, abroad)
- 2018
-
- NK VUE product approval in Indonesia, Kazakhstan, and Singapore
- NK VUE supply agreement signed with major Canadian diagnostics laboratories
- Patent registration completed for NK VUE (5 patent, abroad)
- Patent registration completed for SuperNK (2 patents, abroad)
- Partnership agreement signed with Fukuoka Clinic
- 2017
-
- NK VUE supply agreement signed with USA, Indonesia, and Kazakhstan
- NK VUE supply agreement signed with major commercial laboratories in Korea
- NK VUE product approval in Thailand and product approval / public reimbursement in Turkey
- Patent registration completed for NK VUE (2 patent, abroad)
- Set up a corporation office in USA (NKMAX America)
- Set up a corporation office in Japan (NKMAX Japan)
- 2016
-
- Patent for NK cell culture and treatment technology acquisition (SuperNK)
- ATGen H&D, an ATGen subsidiary company, was founded
- NKMAX, an ATGen affiliate company, was founded
- NK VUE public reimbursement in Korea
- Patent registration completed for NK VUE (2 patents, abroad)
- 2015
-
- Listed on KOSDAQ with a special case of technology
- 2014
-
- Set up a corporation office in Canada (ATGen Canada)
- New Health Technology approved in Korea/ NK VUE approved in Canada
- KGMP certificate/ Canada ISO 13485 certification
- Europe CE certification
- Patent registration completed for NK VUE (1 patent, Korea)
- 2013
-
- Selected as promising SME by Gyeonggi Province
- ISO 13485 certification
- Patent registration completed for NK VUE (1 patent, Korea)
- 2012
-
- Overseas revenue $1M
- PCT Patent registration for NK VUE (1 patent)
Growth ( 2006 - 2010 )
- 2009
-
- Developed test kit for influenza enzyme linked immunosorbent assay
- Established Direct online sales system
- 2007
-
- 2006
-
- Designated as a Promising Export Company
Building Foundation ( Start - 2005 )
- 2005
-
- Patent registration completed for SP fusion technology (1 patent, Korea)
- 2004
-
- 2003
-
- Venture Company Certification
- Founded ATGen